Large‐Scale Analysis of the Thalassemia Mutation Spectrum in Guizhou Province, Southern China, Using Third‐Generation Sequencing
Clinical Genetics · 2025
DOI: 10.1111/cge.14729 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2025. Verfasst von Ying Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Medical Laboratory, Zunyi Medical University, Zunyi, Guizhou, China. Hauptthemen laut MEDLINE: Mutation, beta-Thalassemia, alpha-Thalassemia, Thalassemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Department of Science and Technology in Guizhou, China.
Abstract (Originalsprache)
This study aimed to comprehensively characterize the molecular spectrum of thalassemia by retrospectively analyzing genetic screening results from a large cohort of individuals. Peripheral blood samples were collected from 26 047 individuals seeking care at the Departments of Obstetrics and Gynecology, Pediatrics, Reproductive Medicine, and Hematology across multiple regional hospitals in Guizhou Province, China. Thalassemia gene mutations were analyzed using targeted third‐generation sequencing (TGS) to assess the mutation spectrum in this population. Of the cohort, 5099 individuals were identified as thalassemia carriers, yielding an overall carrier rate of 19.58%. The carrier rates differed significantly between the southern and northern regions of Guizhou ( p < 0.001). α‐thalassemia included 40 distinct genotypes, β‐thalassemia comprised 33 genotypes, and cases with concurrent α‐ and β‐thalassemia mutations exhibited 47 unique genotypes. A total of 17 distinct mutations were identified in the α‐thalassemia gene and 26 in the β‐thalassemia gene. The mutation spectrum in Guizhou showed significant differences when compared to other southern Chinese populations, with notable regional variations within Guizhou itself. This study highlights the substantial genetic diversity and distinct mutation patterns of thalassemia in Guizhou Province. These findings provide valuable insights into the distribution of thalassemia genotypes and alleles, which can inform genetic counseling and prenatal screening strategies tailored to this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medical Laboratory, Zunyi Medical University, Zunyi, Guizhou, China.
- Department of Clinical Laboratory, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
- Department of Medical Genetics, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
- School of Medicine, Guizhou University, Guiyang, Guizhou, China.
- Kingmed Medical Laboratory Center, Guiyang, Guizhou, China.
ORCID-Profile: Lingyan Ren
Förderung
- National Natural Science Foundation of China
- Department of Science and Technology in Guizhou, China
Zitieren
APA
Zhang, Y., Wu, J., Ren, L., Li, F., Wu, X., Guo, M., You, G., Fu, Z., Long, G., & Huang, S. (2025). Large‐Scale Analysis of the Thalassemia Mutation Spectrum in Guizhou Province, Southern China, Using Third‐Generation Sequencing. Clinical Genetics. https://doi.org/10.1111/cge.14729
Vancouver
Zhang Y, Wu J, Ren L, Li F, Wu X, Guo M, et al. Large‐Scale Analysis of the Thalassemia Mutation Spectrum in Guizhou Province, Southern China, Using Third‐Generation Sequencing. Clinical Genetics. 2025. doi:10.1111/cge.14729
BibTeX
@article{Zhang2025,
author = {Zhang, Ying and Wu, Jiangfen and Ren, Lingyan and Li, Fangfang and Wu, Xian and Guo, Min and You, Guiqin and Fu, Zhengqian and Long, Guiping and Huang, Shengwen},
title = {Large‐Scale Analysis of the Thalassemia Mutation Spectrum in Guizhou Province, Southern China, Using Third‐Generation Sequencing},
journal = {Clinical Genetics},
year = {2025},
doi = {10.1111/cge.14729}
}
EUVIMED